Fat distribution, HbA1c and hypoglycaemia in overweight and obese patients with type 2 diabetes: a comparison of NPH and insulin detemir from a pilot randomised clinical trial

被引：0
|
作者：
Tinahones, F. J. [1 ]
Gomez-Huelgas, R. [2 ]
Garcia-Alegria, J. [3 ]
Tapia-Guerrero, M.
Martos-Perez, F. [4 ]
机构：
[1] Hosp Virgen de la Victoria, Malaga, Spain
[2] Hosp Carlos Hayer, Dept Internal Med, Malaga, Spain
[3] Hosp Costa del Sol, Marbella, Spain
[4] Hosp Alta Resoluc, Benalmadena, Spain
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
671
引用
收藏
页码：S273 / S273
页数：1
相关论文
共 50 条
  • [21] Effects of nutrition therapy on HbA1c and cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes
    Mottalib, Adham
    Salsberg, Veronica
    Mohd-Yusof, Barakatun-Nisak
    Mohamed, Wael
    Carolan, Padraig
    Pober, David M.
    Mitri, Joanna
    Hamdy, Osama
    NUTRITION JOURNAL, 2018, 17
  • [22] Impact of HbA1c and sulfonylurea use on hypoglycaemia in type 2 diabetes mellitus
    Clements, K.
    Bron, M.
    Taylor, D.
    Emptage, N.
    Hudgens, S.
    Dabbous, O.
    DIABETOLOGIA, 2010, 53
  • [23] A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIAL
    Buysman, E.
    Aagren, M.
    Liu, F.
    Bouchard, J.
    Conner, C.
    VALUE IN HEALTH, 2011, 14 (07) : A481 - A481
  • [24] Relationship of baseline HbA1c and HbA1c reduction following insulin therapy in Type 2 diabetes
    Giugliano, D.
    Esposito, K.
    DIABETIC MEDICINE, 2011, 28 (02) : 247 - 247
  • [25] Less weight gain and hypoglycaemia with once-daily insulin detemir than with NPH insulin in basal-bolus therapy of overweight type 2 diabetes patients: The PREDICTIVE-BMT trial
    Montanana, C. Fajardo
    Herrero, C. Hernandez
    Fernandez, M. Rivas
    DIABETOLOGIA, 2007, 50 : S404 - S404
  • [26] Addition of alogliptin to insulin therapy reduces HbA1c without increasing weight gain or hypoglycaemia in patients with type 2 diabetes
    Rendell, M.
    Rosenstock, J.
    Gross, J.
    Fleck, P.
    Wilson, C.
    Mekki, Q.
    DIABETOLOGIA, 2008, 51 : S37 - S38
  • [27] HbA1c reduction at week 12 predicts treatment outcome with Orlistat in patients with Type 2 diabetes who are overweight/obese
    Hollander, P
    Ruof, J
    DIABETOLOGIA, 2002, 45 : A220 - A220
  • [28] The effect of CPAP on insulin resistance and HbA1c in people with obstructive sleep apnoea and type 2 diabetes: A randomised controlled trial
    West, S. D.
    Nicoll, D. J.
    Wallace, T. M.
    Matthews, D. R.
    Stradling, J. R.
    THORAX, 2006, 61 : II54 - II54
  • [29] Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials
    Giugliano, D.
    Maiorino, M.
    Bellastella, G.
    Chiodini, P.
    Esposito, K.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (05) : 602 - 612
  • [30] Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes - A randomized clinical trial
    Home, P
    Bartley, P
    Russell-Jones, D
    Hanaire-Broutin, H
    Heeg, JE
    Abrams, P
    Landin-Olsson, M
    Hylleberg, B
    Lang, H
    Draeger, E
    DIABETES CARE, 2004, 27 (05) : 1081 - 1087
12345